TG Therapeutics, Inc. (TGTX) short interest & options flow
NASDAQTGTX reports Q3 results on November 9 carrying one of the heavier short positions in the biotech space, yet the lending market tells a more relaxed story than the headline figure suggests. Short interest has held remarkably steady around 20% of the free float, closing the most recent session at 19.8%. That is a meaningful short position, ranking in the bottom 7th percentile on the…
- Market cap
- $9.00B
- Next earnings
- 26 Feb 2027
Key data as of 11 Nov 2026

TGTX news and analysis
RSSNo long-form analysis yet for TGTX. Pulse alerts and the live data picture are available on ORTEX.
Open TGTX on ORTEX →Want the live picture for TGTX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TGTX — free to start on ORTEX.
Sign up for free →Open TGTX on ORTEX